PRINCIPAL FINANCIAL GROUP INC - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 153 filers reported holding OCULAR THERAPEUTIX INC in Q1 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.9%.

Quarter-by-quarter ownership
PRINCIPAL FINANCIAL GROUP INC ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q2 2024$180,330
-28.9%
26,364
-5.4%
0.00%
Q1 2024$253,708
+159.1%
27,880
+27.0%
0.00%
Q4 2023$97,937
+41.3%
21,959
-0.5%
0.00%
Q3 2023$69,303
-39.6%
22,071
-0.8%
0.00%
Q2 2023$114,789
-4.8%
22,246
-2.7%
0.00%
Q1 2023$120,530
+74.6%
22,871
-6.9%
0.00%
Q4 2022$69,030
-17.8%
24,566
+22.2%
0.00%
Q3 2022$84,000
+1.2%
20,095
-2.3%
0.00%
Q2 2022$83,000
+20.3%
20,571
+46.6%
0.00%
Q1 2022$69,000
-24.2%
14,035
+7.7%
0.00%
Q4 2021$91,000
-93.8%
13,036
-91.1%
0.00%
-100.0%
Q3 2021$1,458,000
-29.2%
145,741
+0.4%
0.00%0.0%
Q2 2021$2,059,000
+325.4%
145,200
+391.7%
0.00%
Q1 2021$484,000
-22.9%
29,529
-2.8%
0.00%
Q4 2020$628,000
-72.3%
30,365
-43.8%
0.00%
-100.0%
Q1 2015$2,268,000
-22.2%
54,000
-56.5%
0.00%
-40.0%
Q4 2014$2,916,000124,0000.01%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q1 2021
NameSharesValueWeighting ↓
SUMMER ROAD LLC 3,784,850$15,064,00062.56%
Versant Venture Management, LLC 2,215,384$8,817,228,0004.36%
SV Health Investors, LLC 628,236$2,500,0001.54%
DELTEC ASSET MANAGEMENT LLC 724,747$2,885,0000.80%
Endurant Capital Management LP 232,727$926,0000.49%
NOTTINGHAM ADVISORS, INC. 146,946$1,011,0000.15%
JGP Global Gestao de Recursos Ltda. 12,568$50,0000.06%
Man Group plc 1,187,508$4,726,0000.02%
Dynamic Technology Lab Private Ltd 21,077$84,0000.02%
NewEdge Advisors, LLC 36,250$144,0000.01%
View complete list of OCULAR THERAPEUTIX INC shareholders